| A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial R Nachbagauer, J Feser, A Naficy, DI Bernstein, J Guptill, EB Walter, ... Nature medicine 27 (1), 106-114, 2021 | 261 | 2021 |
| Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli ΔtolR IHE3034 mutant FB Scorza, F Doro, MJ Rodríguez-Ortega, M Stella, S Liberatori, ... Molecular & Cellular Proteomics 7 (3), 473-485, 2008 | 196 | 2008 |
| Self-amplifying mRNA vaccines GAJ Brito LA, Kommareddy S, Maione D, Uematsu Y, Giovani C, Berlanda Scorza ... Nonviral Vectors for Gene Therapy Physical Methods and Medical Translation …, 2015 | 191* | 2015 |
| Universal influenza vaccines: Shifting to better vaccines FB Scorza, V Tsvetnitsky, JJ Donnelly Vaccine 34 (26), 2926-2933, 2016 | 179 | 2016 |
| High Yield Production Process for Shigella Outer Membrane Particles F Berlanda Scorza, AM Colucci, L Maggiore, S Sanzone, O Rossi, ... PloS one 7 (6), e35616, 2012 | 165 | 2012 |
| The Caenorhabditis elegans Elongator Complex Regulates Neuronal α-tubulin Acetylation JA Solinger, R Paolinelli, H Klöß, FB Scorza, S Marchesi, U Sauder, ... PLoS genetics 6 (1), e1000820, 2010 | 135 | 2010 |
| A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies R Nachbagauer, WC Liu, A Choi, TJ Wohlbold, T Atlas, M Rajendran, ... npj Vaccines 2 (1), 26, 2017 | 133 | 2017 |
| Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial DI Bernstein, J Guptill, A Naficy, R Nachbagauer, F Berlanda-Scorza, ... The Lancet Infectious Diseases 20 (1), 80-91, 2020 | 130 | 2020 |
| Proteins and nucleic acids from meningitis/sepsis-associated Escherichia coli V Masignani, DG Moriel, FB Scorza, N Norais, MR Fontana, M Pizza, ... US Patent 8,758,764, 2014 | 127 | 2014 |
| Breathing life into pathogens: the influence of oxygen on bacterial virulence and host responses in the gastrointestinal tract B Marteyn, FB Scorza, PJ Sansonetti, C Tang Cellular Microbiology 13 (2), 171-176, 2011 | 121 | 2011 |
| Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro E Bartolini, E Ianni, E Frigimelica, R Petracca, G Galli, F Berlanda Scorza, ... Journal of extracellular vesicles 2 (1), 20181, 2013 | 113 | 2013 |
| A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements MME Metruccio, E Pigozzi, D Roncarati, F Berlanda Scorza, N Norais, ... PLoS pathogens 5 (12), e1000710, 2009 | 104 | 2009 |
| New kids on the block: RNA-based influenza virus vaccines FB Scorza, N Pardi Vaccines 6 (2), 20, 2018 | 94 | 2018 |
| Prophylaxis and Treatment against Klebsiella pneumoniae: Current Insights on This Emerging Anti-Microbial Resistant Global Threat V Arato, MM Raso, G Gasperini, F Berlanda Scorza, F Micoli International Journal of Molecular Sciences 22 (8), 4042, 2021 | 57 | 2021 |
| Sequential immunization with live-attenuated chimeric hemagglutinin-based vaccines confers heterosubtypic immunity against influenza A viruses in a preclinical ferret model WC Liu, R Nachbagauer, D Stadlbauer, A Solórzano, F Berlanda-Scorza, ... Frontiers in immunology 10, 756, 2019 | 57 | 2019 |
| Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015 BK Giersing, K Modjarrad, DC Kaslow, VS Moorthy, A Bavdekar, ... Vaccine 34 (26), 2865-2869, 2016 | 56 | 2016 |
| GMMA-based vaccines: the known and the unknown F Mancini, F Micoli, F Necchi, M Pizza, F Berlanda Scorza, O Rossi Frontiers in Immunology 12, 715393, 2021 | 45 | 2021 |
| RNA purification methods FB Scorza, Y Wen, A Geall, F Porter US Patent 11,155,572, 2021 | 32* | 2021 |
| Towards a Four-Component GMMA-Based Vaccine against Shigella F Micoli, UN Nakakana, F Berlanda Scorza Vaccines 10 (2), 328, 2022 | 28 | 2022 |
| Proteins and nucleic acids from meningitis/sepsis-associated Escherichia coli V Masignani, DG Moriel, FB Scorza, N Norais, MR Fontana, M Pizza, ... US Patent 9,334,313, 2016 | 22 | 2016 |
Mariagrazia PizzaGSK Vaccines - Imperial College在 imperial.ac.uk 的电子邮件经过验证
